Do you want to read an article? Please log in or register.
Biomarkers of risk of switching to dexamethasone implant for the treatment of diabetic macular oedema in real clinical practice: a multicentric study
Macular Diseases
Related content
Macular Diseases
Intravitreal Dexamethasone Implant in Anti-Vascular Endothelial Growth Factor Pretreated Diabetic Macular Edema-A Swiss Cohort Study
Pharmaceuticals (Basel)
Turgut F, Somfai GM, Tappeiner C, Hatz K, Mantel I, Ambresin A, Donati G, Guignard V, Nagyová D, Pfister IB, Schild C, Garweg JG
doi: 10.3390/ph17091235
Macular DiseasesFurther Publications
Vitrectomy as an Adjunct to Treat-and-Extend Anti-VEGF Injections for Diabetic Macular Edema: The Vitrectomy in Diabetic Macular Oedema (VIDEO) Randomized Clinical Trial
JAMA Ophthalmol
Maguire MJ, Laidlaw A, Hammond C, Muqit MMK, Steel D, Dinah C, Lee E, Hillier R, Almeida G, Hussain R, Gordon-Bennet P, Hughes E, Alexander P, Vaideanu-Collins D, Jackson T
doi: 10.1001/jamaophthalmol.2024.2777
Macular Diseases
Treat-and-Extend Versus Pro re nata Regimens of Ranibizumab and Aflibercept in Neovascular Age-Related Macular Degeneration: A Comparative Study from Routine Clinical Practice
Ophthalmol Ther
Debourdeau E, Beylerian H, Nguyen V, Barthelmes D, Gillies M, Gabrielle PH, Vujosevic S, Otoole L, Puzo M, Creuzot-Garcher C, Wolff B, Daien V, Fight Retinal Blindness! Study Group
doi: 10.1007/s40123-024-00983-2
Glaucoma and Ocular PressureMacular DiseasesRetinal Diseases
Secondary ocular hypertension as an adverse effect of treatment with intravitreal dexamethasone implant: A retrospective Swedish cohort study
Acta Ophthalmol
Abu Ishkheidem I, Breimer M, Kamal S, Zetterberg M, Al-Hawasi A, Grönlund MA
doi: 10.1111/aos.17475
Macular Diseases
Real-World Outcomes of Different Types of Treatment for Diabetic Macular Edema Before and After Approval of Anti-Vascular Endothelium Growth Factor Agents
J Clin Med
Sugimoto M, Chujo S, Kato K, Shimura M, Kitano S, Kusuhara S, Terasaki H, Kondo M, Writing Committee Of Japan-Clinical Retina Study Group J-Crest
doi: 10.3390/jcm13237336
Macular Diseases
Intravitreal faricimab for treatment naïve patients with neovascular age-related macular degeneration: a real-world prospective study
Int J Retina Vitreous
Grimaldi G, Cancian G, Paris A, Clerici M, Volpe G, Menghini M
doi: 10.1186/s40942-024-00586-w
Macular Diseases
Comparison of subconjunctival TRIamcinolone acetonide injection and intravitreal dexamethasone (OZurdex) injection for uveitic and postoperative macular oedema: the TRIOZ study
Br J Ophthalmol
Couret C, Quintart PA, Poinas A, Vibet MA, Le Lez ML, Labalette P, Bodaghi B, Labetoulle M, Rougier MB, Angioi K, Chiquet C, Titah C, Kodjikian L, Baillif S, Creuzot-Garcher C, Errera MH, Weber M
doi: 10.1136/bjo-2023-325128
RECOMMENDED
Macular DiseasesFurther Publications
Cocoa Flavanol Supplementation and Risk of Age-Related Macular Degeneration: An Ancillary Study of the COSMOS Randomized Clinical Trial
★ 1
Recommended by
Prof. emer. Dr Josef Flammer, Faculty Member
JAMA Ophthalmol
Christen WG, Rist PM, Moorthy MV, Smith DC, Holman B, Clar A, Glynn RJ, Mares JA, Sobrin L, Shadyab AH, Allison MA, Millen AE, Manson JE, Sesso HD, COSMOS Research Group
doi: 10.1001/jamaophthalmol.2025.0353
Macular Diseases
Differentiating treatment episodes from gaps in eyes with diabetic macular oedema
Br J Ophthalmol
Hashimoto Y, Hunt AR, Silva R, Witmer A, Kheir WJ, Viola F, Arrazola M, Mahgoub MM, Pollreisz A, Harvey Z, Barthelmes D, Gillies MC
doi: 10.1136/bjo-2025-327238